The merger spread is getting larger by the day.
CI derives less than 2% of total revenue from China, which is still a very fast growing market for them as organized health care is still in its infancy.
So all of the talk of the deal not getting done because it will hurt consumers is bogus and moot. If anything, the insurers will be in a much better position to negotiate with the hospitals, doctors and drug companies who are the ones fleecing the American public and could actually LOWER rates to consumers. The deal with ANTM will get done, with a minor divestiture or two.
As the analyst who upgraded CI to strong buy with a $190 target today noted, the stock represents an "extremely compelling" investment opportunity